Cline Scientific initiates collaboration with global biopharmaceutical company with the aim of uncovering core mechanisms of vascular disease
Cline Scientific has entered into a collaboration with AstraZeneca to utilise Cline’s gradient technology as part of the multi-country European MSCA-ITN network, V.A Cure . V.A Cure is a Horizon 2020 funded project which aims to uncover core mechanisms of vascular anomalies and to leverage this information for establishing new therapeutics for vascular disease. The project consists of 14 individual research projects across seven academic labs and two industry partners. Vascular anomalies are defects of the